4-Antibody AG - Product Pipeline Review - Q1 2011

Global Markets Direct, May 2011, Pages: 17

4-Antibody AG – Product Pipeline Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “4-Antibody AG - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- 4-Antibody AG - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of 4-Antibody AG human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of 4-Antibody AG with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the 4-Antibody AG’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate 4-Antibody AG’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of 4-Antibody AG in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the 4-Antibody AG’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with 4-Antibody AG.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of 4-Antibody AG and identify potential opportunities in those areas.

List of Tables
List of Figures
4-Antibody AG Snapshot
4-Antibody AG Overview
Key Information
Key Facts
4-Antibody AG – Research and Development Overview
Key Therapeutic Areas
4-Antibody AG – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
4-Antibody AG – Pipeline Products Glance
4-Antibody AG–Early Stage Pipeline Products
Discovery Products/Combination Treatment Modalities
4-Antibody AG – Drug Profiles
4Ab-028
Product Description
Mechanism of Action
R&D Progress
Antibodies to TNF-Alpha
Product Description
Mechanism of Action
R&D Progress
4-Antibody AG – Pipeline Analysis
4-Antibody AG – Pipeline Products by Therapeutic Class
4-Antibody AG - Pipeline Products By Target
4-Antibody AG – Pipeline Products by Molecule Type
4-Antibody AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
4-Antibody AG – Pipeline by Therapy Area and Indication, 2011
4-Antibody AG – Pipeline by Stage of Development, 2011
4-Antibody AG – Monotherapy Products in Pipeline, 2011
4-Antibody AG - Pipeline By Therapeutic Class, 2011
4-Antibody AG - Pipeline By Target, 2011
4-Antibody AG – Pipeline By Molecule Type, 2011
4-Antibody AG, Other Locations

List of Figures
4-Antibody AG – Pipeline by Therapy Area and Indication, 2011
4-Antibody AG – Pipeline by Stage of Development, 2011
4-Antibody AG – Monotherapy Products in Pipeline, 2011
4-Antibody AG - Pipeline By Target, 2011
4-Antibody AG – Pipeline By Molecule Type, 2011

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• eBay - Strong Execution
• Scientific Games Corporation - Company Analysis
• Amazon - Point of Realization in 2013?
• SunGard - Profile - US
• Insight into Samsung Electronics' Notebook PC Business Model
• Ixia - Company Analysis
• SAP AG,(SAP) Profile and Financials, plus E-Commerce & Internet Industry Trends Analysis, Operating Ratio and Financial Averages